Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Kim

Showing results (351-360 of 529) with videos related to

Pageof 53
Sort By:
Tissue Antigens|April 21, 2007
Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in KoreansS-Y Kim, H-B Choi, H-Y Yoon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 6, 2025
Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitisH S Rugo, E Tokunaga, H Iwata, et al.
Lupus|August 2, 2001
FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patientsH R Yun, H K Koh, S S Kim, et al.
Leukemia|November 13, 2010
The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular responseE K Jeon, J Lim, M Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2019
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001A T Shaw, G J Riely, Y-J Bang, et al.
British Journal of Cancer|November 13, 2008
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectivesJ W Kim, S-J Kim, Y-H Chung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOSY-L Wu, D Planchard, S Lu, et al.
British Journal of Cancer|March 5, 2009
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survivalJ-S Kim, M-A Kim, T M Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2013
Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory studyJ K Lee, J-Y Shin, S Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2022
Discovery of a functionally selective ghrelin receptor (GHSR<sub>1a</sub>) ligand for modulating brain dopamineJ D Gross, D W Kim, Y Zhou, et al.
Pageof 53

Showing results (351-360 of 529) with videos related to

Sort By:
Pageof 53
Tissue Antigens|April 21, 2007
Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in KoreansS-Y Kim, H-B Choi, H-Y Yoon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 6, 2025
Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitisH S Rugo, E Tokunaga, H Iwata, et al.
Lupus|August 2, 2001
FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patientsH R Yun, H K Koh, S S Kim, et al.
Leukemia|November 13, 2010
The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular responseE K Jeon, J Lim, M Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2019
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001A T Shaw, G J Riely, Y-J Bang, et al.
British Journal of Cancer|November 13, 2008
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectivesJ W Kim, S-J Kim, Y-H Chung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOSY-L Wu, D Planchard, S Lu, et al.
British Journal of Cancer|March 5, 2009
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survivalJ-S Kim, M-A Kim, T M Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2013
Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory studyJ K Lee, J-Y Shin, S Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2022
Discovery of a functionally selective ghrelin receptor (GHSR<sub>1a</sub>) ligand for modulating brain dopamineJ D Gross, D W Kim, Y Zhou, et al.
Pageof 53